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Summary
Background: The eukaryotic cell cycle begins with a burst of
cyclin-dependent kinase (Cdk) phosphorylation. In budding
yeast, several Cdk substrates are preferentially phosphory-
lated at the G1/S transition rather than later in the cell cycle
when Cdk activity levels are high. These early Cdk substrates
include signaling proteins in the pheromone response path-
way. Two such proteins, Ste5 and Ste20, are phosphorylated
only when Cdk is associated with the G1/S cyclins Cln1 and
Cln2 and not G1, S, or M cyclins. The basis of this cyclin spec-
ificity is unknown.
Results: Here we show that Ste5 and Ste20 have recognition
sequences, or ‘‘docking’’ sites, for the G1/S cyclins. These
docking sites, which are distinct from Clb5/cyclin A-binding
‘‘RXL’’ motifs, bind preferentially to Cln2. They strongly
enhance Cln2-driven phosphorylation of each substrate in vivo
and function largely independent of position and distance to
the Cdk sites. We exploited this functional independence to
rewire a Cdk regulatory circuit in a way that changes the target
of Cdk inhibition in the pheromone response pathway. Further-
more, we uncover functionally active Cln2 docking motifs
in several other Cdk substrates. The docking motifs drive
cyclin-specific phosphorylation, and the cyclin preference
can be switched by using a distinct motif.
Conclusions: Our findings indicate that some Cdk substrates
are intrinsically capable of being phosphorylated by several
different cyclin-Cdk forms, but they are inefficiently phosphor-
ylated in vivo without a cyclin-specific docking site. Docking
interactions may play a prevalent but previously unappreci-
ated role in driving phosphorylation of select Cdk substrates
preferentially at the G1/S transition.
Introduction
Cyclin-dependent kinases (Cdks) are central regulatory
enzymes of the eukaryotic cell cycle [1]. In most eukaryotes,
different Cdk forms are specialized for driving distinct events
in the cell cycle. In metazoans, these forms can differ in both
the cyclin subunit and the Cdk enzyme. In simpler eukaryotes
such as yeasts, a single Cdk enzyme associates with multiple
different cyclins, which impart different functional properties
to the cyclin-Cdk complex. Theways inwhich the cyclin affects
these properties are understood partly, though still incom-
pletely. For example, cyclins can affect the specific activity
of the Cdk enzyme, the interaction with particular substrates,
or the targeting to distinct subcellular locations [2, 3].
In the budding yeast Saccharomyces cerevisiae, a single
Cdk protein (Cdc28) associates with nine different cyclins*Correspondence: peter.pryciak@umassmed.edu[2, 4]. Six B-type cyclins (Clb1–Clb6) drive DNA synthesis and
mitosis (S and M phases), whereas the transition from G1 to S
phase is driven by the G1 cyclin Cln3 and the G1/S cyclins
Cln1 and Cln2. Although there is functional overlap, these var-
ious cyclins are clearly specialized for optimumperformanceof
discrete tasks. Even the three semiredundant Cln proteins
show functional distinctions, because cln3D and cln1D cln2D
cells each display unique phenotypic defects [5–8]. Interest-
ingly, there are several Cdk substrates whose phosphorylation
peaks during maximum expression of Cln1/2 [9–12], and it is
not clear why later cyclins are less effective; e.g., despite the
fact that the M phase cyclin Clb2 confers especially strong
Cdk activity [13], some substrates are phosphorylated more
readily by Cln2-Cdc28 than by Clb2-Cdc28. To date, no
molecular mechanism explains why any particular substrate
is preferentially phosphorylated in a Cln1/2-specific manner.
Cln1/2-specific substrates include proteins in the phero-
mone response pathway. This signaling pathway triggers a
G1 phase arrest that synchronizes cells prior to mating
[14, 15]. In cells that have already begun the cell cycle, this
pathway is transiently inactivated so that cell division can
conclude [16, 17]. Three proteins in this pathway are phos-
phorylated at theG1/S transition: Far1 (a Cdk inhibitor protein),
Ste20 (a member of the p21-activated kinase [PAK] family),
and Ste5 (a mitogen-activated protein kinase [MAPK] cas-
cade scaffold protein) [10–12, 18]. Whereas the role of
Ste20 phosphorylation remains unknown [19], Cdk phosphor-
ylation of Far1 and Ste5 inactivates the cell-cycle arrest and
signal transduction functions of the pheromone pathway,
respectively [12, 18, 20]. Notably, Ste20 and Ste5 are
Cln1/2-specific substrates [10–12], but the mechanistic basis
of this specificity is unknown. S phase cyclins such as
mammalian cyclin A and yeast Clb5 have a ‘‘hydrophobic
patch’’ that allows them to recognize specific ‘‘RXL’’ motifs
in some substrates [21–23]. Some related examples exist for
other cyclins [24, 25], but not for the yeast G1 or G1/S cyclins.
Moreover, as with many Cdk substrates, Ste20 and Ste5 are
each phosphorylated at a large number of sites, and this can
be important for proper regulation [12].
In this study, we probe the molecular basis of cyclin speci-
ficity during G1/S Cdk phosphorylation in vivo. We find that
both Ste5 and Ste20 have specific recognition sequences,
or docking sites, that interact preferentially with the cyclin
Cln2. In each protein, the docking sites promote efficient phos-
phorylation of Cdk sites, and they do so in a cyclin-specific
manner. Furthermore, these docking sites function largely
irrespective of distance or orientation relative to the phos-
phorylation sites, and they are interchangeable between sub-
strates. We identify functionally similar behavior for motifs in
several other Cdk substrates, suggesting that these docking
sites may represent the first of many previously unrecognized
recognition sequences for the G1 or G1/S cyclins in yeast.
Results
Cyclin-Specific Phosphorylation of Ste5 and Ste20
Pheromone responsiveness rises and falls in opposition to the
periodic fluctuations in Cln1/2 levels [16, 17]. Similarly, both
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Figure 1. Cyclin-Specific Phosphorylation of Ste5 and Ste20 Regulatory
Domains
(A) Domain structures of Ste5 and Ste20. Red circles indicate Cdk sites
[12, 19]; in Ste20, only the 13 confirmed sites (of 23 possible) are shown.
(B) Phosphorylation of Ste5 and Ste20 fragments in synchronous cdc15-2
cultures, after release from M phase arrest. Full-length Ste20 is shown for
comparison; its phosphorylation behavior has been described previously
[10, 11]. Cell-cycle progression was monitored by anti-Clb2 immunoblot
and by budding.
(C) Hemagglutinin epitope-tagged Ste5 or V5-tagged Ste20 fragments, ex-
pressed from native promoters, were monitored after galactose-induced
expression of glutathione S-transferase (GST)-tagged cyclins. Reduced
electrophoretic mobility signifies phosphorylation, as confirmed by phos-
phatase treatment (data not shown). For comparison, V5-tagged Swe1
demonstrates activity for Clb2. The relative expression levels for GST-cy-
clins were highly reproducible; one representative example is shown. A
variant of Cln3 lacking ten Cdk sites (Cln310A) was used to increase its
stability. Results were similar in sic1D cells (data not shown), in which the
Clb-Cdk inhibitor Sic1 is absent.
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dependent on Cln1/2 cyclins [10–12]. To investigate the basis
of this cyclin specificity, we asked whether it is an intrinsic
feature of the Cdk phosphorylation sites themselves or
whether it involves other structural or functional features of
each substrate protein. Ste5 and Ste20 are large, multidomain
proteins (>900 residues) that can be roughly divided into
N-terminal regulatory/localization regions and C-terminal
catalytic/signaling regions (Figure 1A). In each case, the Cdk
sites are concentrated in the N-terminal regions. Using
N-terminal fragments of each protein (Ste51–370, Ste51–337,
Ste2080–590) as substrates, we found that cyclin specificity
was maintained. First, their phosphorylation in synchronous
cultures peaked at the G1/S boundary (bud emergence; Fig-
ure 1B) rather than in M phase (when levels of Clb2 were
maximal). Second, when using the inducible GAL1 promoter
(PGAL1) to drive expression of various cyclins, phosphorylation
of the Ste5 and Ste20 fragments was observed only with Cln1
and Cln2 and not with Cln3, Clb5, or Clb2 (Figure 1C).
(Although unequal levels of cyclins could contribute to these
differences, Clb2 was able to drive phosphorylation of the
Cdk substrate Swe1 [Figure 1C] [26], and later results will
show activity for both Clb5 and Clb2 in similar assays.) Thus,
stage-specific and cyclin-specific phosphorylation of Ste5
and Ste20 do not require their signaling functions, and the
determinants of specificity must lie within their N-terminal
fragments.
A Distal Recognition Sequence Promotes Cdk
Phosphorylation of the Ste5 N Terminus
We used the Ste51–337 fragment to study the requirements for
phosphorylation by Cln2-Cdc28. As expected, phosphoryla-
tion required the same eight Cdk sites shown previously to
regulate full-length Ste5 (Figure 2B) [12]. Nevertheless, these
sites were not sufficient to ensure efficient phosphorylation.
By making further truncations, we discovered that phosphory-
lation required a short stretch of sequence (276–283) far away
from the Cdk sites (Figure 2B). Similarly, alanine replacement
of four residues within this region (LLPP) also disrupted phos-
phorylation (Figure 2B). In contrast, internal deletions showed
that several other large segments of the Ste5 N terminus were
dispensable (Figure 2B). We conclude that efficient Cln2-
Cdc28 phosphorylation of Ste5 requires specific sequences
that are separate from the phosphorylation sites themselves.
For now, we tentatively refer to this required region as a Cln2
docking site.
This putative Cln2 docking site lies within a larger interdo-
main region of Ste5 with several notable features (see Fig-
ure S1A available online), including (1) a MAPK binding site;
(2) four MAPK phosphorylation sites, which possibly could
also act as Cdk sites as a result of similar target sequences
(i.e., S/T-P); and (3) a binding site for the phosphatase
Ptc1 [27, 28]. None of these features seemed crucial for
docking site function. MAPK binding played no evident role,
because the results were unaffected by deleting MAPK genes
(fus3D kss1D) or by mutating the MAPK binding site (ND
mutant) (Figure 2C; Figure S1B). At the MAPK phosphoryla-
tion sites, phosphomimetic mutations (4E) had no effect
(Figure 2C), but nonphosphorylatable mutations (4AV) caused
a mild reduction; thus, phosphorylation at one or more of
these sites (e.g., by a MAPK or Cdk) may enhance further
Cdk phosphorylation elsewhere, or the mutations may mildly
disrupt recognition of the docking motif. (All four MAPK sites
cannot be required, because the shorter Ste51–283 fragmentretains only two sites yet remains a good substrate; Fig-
ures 2B and 2C.) Finally, although the required LLPP motif
overlaps a binding site for Ptc1 [28], it promoted Cdk phos-
phorylation identically in ptc1D cells (Figure 2C; Figure S1C).
Altogether, these data show that recognition of the putative
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Figure 2. A Distal Docking Motif Promotes Cln2-Cdc28 Phosphorylation of Ste5
(A) Locations of key Ste5 features and mutations. Residues 275–283 contain the putative Cln2 docking motif required for efficient phosphorylation of the
N-terminal Cdk sites. Mutations used in later panels are indicated; see Figure S1A for details.
(B) Phosphorylation of the Ste5 N terminus (Ste51–337) requires both the Cdk sites and a distal LLPP motif between residues 275 and 283. Phosphorylation
was triggered by galactose-induced expression of a PGAL1-CLN2 construct (+) or a vector control (2).
(C) The role of the LLPP motif is independent of mitogen-activated protein kinases (MAPKs) (fus3D kss1D), the phosphatase Ptc1 (ptc1D), and the MAPK
binding site (ND mutant). Results show the Ste51–337 fragment except as indicated otherwise. The fus3D kss1D strain (PPY1173) was tested in parallel with
a congenic wild-type strain (PPY640). LLPP function also does not require the MAPK phosphorylation sites, but nonphosphorylatable mutations at these
sites (4AV) mildly reduce the extent of Cln2-Cdc28 phosphorylation. See also Figures S1B and S1C.
(D) Cln2-driven phosphorylation of full-length Ste5 (V5-tagged) requires the LLPP motif. For the 8A lanes, a longer exposure (of the same blot) is shown to
compensate for imperfect loading.
(E) Mutation of the LLPP motif disrupts the ability of Cln2 to inhibit pheromone signaling. Pheromone-induced phosphorylation of Fus3 was monitored in
ste5D fus3D kss1D strains (6PGAL1-CLN2) harboring STE5 variants and wild-type FUS3 on plasmids.
(F) The LLPP motif mediates regulation by Cln2 in the absence of Fus3-Ste5 binding (Ste5 ND mutant) and Fus3 kinase activity (fus3-K42Rmutant). Strains
(as in D) harbored plasmids with the indicated forms of STE5 and FUS3.
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1617Cln2 docking site can be separated from MAPK and Ptc1
binding, though it may be affected by either the sequence
or phosphorylation status of adjacent S/T-P sites. Further-
more, as with the N-terminal fragments, the LLPP motif was
also required for Cdk phosphorylation of full-length Ste5
(Figure 2D).
Next, we tested whether the Cln2 docking site is required
for Cdk inhibition of Ste5 signaling [12]. Indeed, as with
mutation of the Cdk sites (8A), mutation of the LLPP motif
restored the ability of pheromone to activate the MAPK
Fus3 in PGAL1-CLN2 cells (Figure 2E). However, this restored
activation was unusually transient (Figure 2E), and the tran-
scriptional response was only partially restored (Figure S1D).
This complex behavior likely reflects the additional role of
the LLPP region in binding to Ptc1, which antagonizes theability of Fus3 to bind Ste5 and downregulate signaling [28].
That is, although the LLPP mutation disrupts Cln2 docking, it
will simultaneously lead to excessive binding and inhibition
by Fus3, which may have a compensatory effect. To eliminate
contributions from Fus3, we used either the Ste5 ND mutation
to disrupt Fus3 binding [27] or a kinase-inactive form of Fus3
(K42R). In these contexts, the LLPP mutation clearly blocked
the inhibitory effect of Cln2 (Figure 2F; Figure S1D). Therefore,
the LLPP motif can mediate Cdk inhibition in the absence of
both Fus3 binding and kinase activity, whereas excess Fus3
activity may obscure this role. Although the overlap between
Cln2 and Ptc1 sites creates an added layer of complexity,
overall these results establish that Cdk regulation of Ste5
involves both Cdk phosphorylation sites and a separate Cln2
docking motif.
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Figure 3. Cyclin-Specific Binding by Docking Motifs in Ste20 and Ste5
(A) The diagram indicates endpoints used for mapping the Cln2-binding
region in Ste20, which is outlined in red.
(B) Cells coexpressing GST fusions to Ste20 fragments and Cln2-myc13
were lysed, and complexes were recovered using glutathione Sepharose.
Input (5%) and bound proteins were analyzed by anti-myc and anti-GST
blots.
(C) Starting with a Ste2072–333 fragment, alanine substitutions were made at
blocks of residues in the 72–118 region (see Figure S2C; numbering starts at
two because additional flanking mutations were used in other assays). Cln2
binding was tested as in (B). Separately, the required Ste20 region was re-
placed by a Ste5263–335 fragment (ii), in both wild-type (WT) and LLPPmutant
forms, to test the ability of this Ste5 sequence to mediate Cln2 binding.
(D) Ste20 and Ste5 docking sites show cyclin-specific binding. GST alone
(2) or GST fusions (+) were used to coprecipitate myc13-tagged cyclins
(expressed from the CYC1 promoter) in yeast lysates. The GST fusions
were to Ste201–333 (Ste20 motif) or to the Ste5263–335-Ste20120–333 chimera
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Efforts to test whether Ste5 binds Cln2 were hampered by
technical issues (e.g., nonspecific precipitation), but binding
of Ste20 to Cln2 is readily detectable in cell extracts [19, 29].
Therefore, we searched for the responsible sequences in
Ste20 using GST-Ste20 and Cln2-myc13 fusions. An N-terminal
fragment (Ste201–333) was sufficient to bind Cln2, and this
required residues 72–119 (Figure 3B). The C-terminal end of
this fragment, which harbors a membrane-binding ‘‘basic-
rich’’ (BR) domain, was not required, but it did enhance binding
(Figure S2B); hence, further analyses kept the C terminus fixed
at position 333. The required region (72–119) includes
a conserved block ofw20 residues (Figure S2C), and mutating
consecutive sets of residues in this region revealed that an
eight-residue stretch (SLDDPIQF) was critical for binding to
Cln2 (Figure 3Ci). We then asked whether the role of this
Ste20 motif could be replaced with a small fragment from
Ste5 that harbors its putative Cln2 docking site. Indeed, the
Ste5 site mediated Cln2 binding, and this required the same
LLPP sequence that promotes Ste5 phosphorylation (Fig-
ure 3Cii). Furthermore, each sequence preferentially bound
to Cln2 over other cyclins (Figure 3D) and bound weakly to
Cln1. Collectively, these experiments identify docking sites in
both Ste20 and Ste5 that can discriminate among different cy-
clins to mediate specific binding. The two sites are not highly
similar but each contains the motif LxxPFxF (where F is
hydrophobic), raising the possibility that a degenerate pattern
of hydrophobic side chains forms the Cln2 recognition motif.
The Cln2 Docking Site in Ste20 Enhances Phosphorylation
Ste20 contains 23 potential Cdk sites, of which at least 13 are
used in vivo [19]. To test whether Cln2 docking affects Ste20
phosphorylation, we compared mutations in either the dock-
ing site (mut3) or the 13 confirmed Cdk sites (cdk*), using
full-length Ste20 and several N-terminal fragments (Figure 3E).
In full-length Ste20 (1–939), the docking site mutation reduced
the magnitude of the Cln2-induced mobility shift but did not
eliminate it (i.e., unlike the cdk* mutation). This partial pheno-
type could signify less efficient use of all sites or a specific
defect at particular sites as a result of their position or se-
quence context; in this regard, it is noteworthy that 9 of the
13 confirmed Cdk sites are ‘‘minimal’’ sites (S/T-P) whereas
only 4 are ‘‘consensus’’ sites (S/T-P-X-K/R). The docking site
mutation again caused a partial phenotype for the largest
N-terminal fragment (80–590), but it caused a strong disruptive
phenotype for smaller fragments such as 80–500 (Figure 3E)
and 80–333 (data not shown). Though we did not parse these
differences further, we note that the two smaller fragments
retain only one consensus Cdk site, raising the possibility
that docking is especially important for phosphorylating
minimal sites. As a separate test of the activity of the Ste20
docking motif, we asked whether it could substitute for the
analogous site in Ste5. Indeed, the Ste20motif restored strongused in (Cii) (Ste5 motif). Cln310A showed varying levels of nonspecific
precipitation but no reproducible binding to either GST fusion.
(E) Cln2-induced phosphorylation was assayed for V5-tagged forms of
full-length Ste20 (1–939) or N-terminal fragments (80–590, 80–500), with or
without mutations in the docking site (mut3) or the 13 confirmed Cdk
sites (cdk*).
(F) The Cln2 docking site from Ste20 can drive phosphorylation of a
heterologous substrate. Phosphorylation was analyzed using Ste51–283
(i), Ste51–260 (ii), andWT or mut3 versions of the Ste20 docking site (residues
80–115) fused to Ste51–260 (iii).
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Figure 4. Rewiring a Cdk Regulatory Circuit with a Ste20Ste5PM Chimera
(A) The Ste20Ste5PM chimeras. Ste20 residues 124–311, containing the membrane-binding BR domain, were replaced with three fragments from Ste5 that
include its membrane-binding PM domain plus seven or eight flanking Cdk sites.
(B) Pheromone signaling by Ste20Ste5PM chimeras is inhibited by Cln2. Because Cln2-Cdk normally inhibits signaling via Ste5, these tests used cells with
a nonphosphorylatable Ste5 variant (ste20DSTE5-8A). Wild-type Ste20 (WT) or Ste20Ste5PM chimeras (fromA) were introduced on plasmids, and pheromone
responsewasmeasured using a transcriptional reporter (FUS1-lacZ). Signaling by all three chimeras (#A, #B, #C) was inhibited by Cln2, but this was blocked
by mutations in the Cdk phosphorylation sites (7A, 8A). Deletions of the Ste20 N terminus, made in the #A chimera, show that residues 87–119 are required
for regulation by Cln2. Bars represent mean 6 standard deviation (SD) (n = 3).
(C) Sequences required for regulation by Cln2 were analyzed using a chimera similar to #A, containing only Ste20 residues 80–109 upstream of Ste51–85
(see Figure S3C). Alanine mutations replaced eight blocks of residues (left) or individual residues in the SLDDPIQF motif (right). These were compared to
an intact sequence (WT) and a chimera that lacks the sequence entirely (2). Signaling was assayed as in (B). Bars represent mean 6 SD (n = 3).
(D) Docking sites from Ste20 (80–115) or Ste5 (257–330) were inserted at different positions (i–iv) into a variant of chimera #A that lacks residues 87–119
(see B). Insertions at position ii also removed residues 1–86. Signaling was assayed as above. Bars represent mean 6 SD (n = 3).
(E) Bud tip localization of Ste20Ste5PM chimera in cycling cells is inhibited via the Cdk sites (7A) and the Cln2 docking site (mut3). Strain BY4741 harbored
GFP-Ste20 plasmids. Representative images show unfixed cells (left); localization was quantified after formaldehyde fixation (right). Bars represent mean6
SD (n = 3 experiments; >150 cells per allele per experiment).
(F) The growth function of Ste20 is inhibited in the Ste20Ste5PM chimera, if Cdk and docking sites are intact. Serial (1/53) dilutions of strain KBY211 harboring
the indicated Ste20 plasmids were incubated at 25 or 36C for 4 days. As a control, the DBR allele removes the BR domain in full-length Ste20 [33].
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1619phosphorylation to the Ste51–260 fragment, and this activity
was blocked by mutations that disrupt Cln2 binding (Fig-
ure 3Fiii). Thus, the Ste20 docking motif can stimulate Cln2-
Cdc28 phosphorylation of native sites in Ste20 or sites in
a heterologous substrate.
Rewiring a Cdk Regulatory Circuit via a Ste20Ste5PM
Chimera
Cdk phosphorylation of Ste5 serves to inhibit pheromone
response at the G1/S transition [12]. We wished to explore
whether the responsible regulatory mechanism could be
moved to other proteins and whether such synthetic ap-
proaches [30, 31] could help to further probe the factors
controlling Cdk regulation. Therefore, we attempted to transfer
the regulatory effects of Cdk phosphorylation from Ste5 ontoSte20. Our rationale stems from the fact that each protein
requires a short membrane-binding motif for its plasma
membrane localization and signaling activity [32, 33], and the
function of the Ste5 motif, termed the PM domain, is inhibited
by phosphorylation at adjacent Cdk sites [12]. Thus, we re-
placed the membrane-binding (BR) motif in Ste20 with Ste5
fragments that contain both the PM domain and its flanking
Cdk sites (Figure 4A) and then asked whether Ste20 now could
be inhibited by Cdk phosphorylation.
The Ste5 PMdomain was a highly effective substitute for the
Ste20BRdomain (Figure 4B), irrespective of the precise size of
the transferred Ste5 fragment. As hypothesized, the function
of these Ste20Ste5PM chimeras in the pheromone response
pathway was inhibited by expression of Cln2 (Figure 4B).
(Because Cln2 ordinarily inhibits pheromone response via
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were inserted into a Ste20Ste5PM chimera lacking its endogenous docking
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1620Ste5, these assays used cells harboring a Cdk-resistant deriv-
ative, Ste5-8A.) Importantly, this inhibition specifically re-
quired intact Cdk sites flanking the PM domain (Figure 4B),
despite the presence of other Cdk sites elsewhere in Ste20.
Moreover, the inhibition was cyclin specific and was not
accompanied by any reduction in protein levels (Figures S4A
and S4B). Thus, these experiments show that the Cdk regula-
tory target in the pheromone pathway can be switched to
a different protein and that the Cdk-inhibited domain from
Ste5 constitutes a portable regulatory module. Furthermore,
inhibition of the Ste20Ste5PM chimera required the region of
Ste20 (residues 87–119) that contains its Cln2 docking site
(Figure 4B, right). This finding establishes two further points:
(1) the mere presence of Cdk sites in the transferred Ste5 frag-
ment is insufficient to make it an effective target of Cdk down-
regulation, and (2) the Cln2 docking site in Ste20 can control
functional regulation via Cdk phosphorylation.
We used the Ste20Ste5PM chimera to dissect which docking
site residues were required for regulatory activity. This func-
tion was fully contained in a 30-residue region (80–109) span-
ning the conserved stretch noted earlier (Figure S3C), and it
required the same eight-residue motif involved in Cln2 binding
(SLDDPIQF) (Figure 4C, left). Notably, no single residue in this
motif was absolutely required, though partial phenotypeswere
seen for mutations at the L, P, and F residues (Figure 4C, right).
Thus, Cln2 docking may involve contacts distributed through-
out themotif. We also found that docking site function is highly
flexible, because it remained active when placed on either side
of the PM domain and up to w280 residues from the nearest
Cdk site (Figure 4D). Moreover, the docking site from Ste5
could also function in the chimera (Figure 4D, right). Finally,
additional tests showed that the Cdk regulation conferred
upon the Ste20Ste5PM chimera is not limited to pheromone
response or to overexpressed Cln2. Specifically, Ste20 per-
forms additional functions in cycling cells, and its ability to
localize to growing bud tips, or to sustain viability in the
absence of the related PAK Cla4, requires plasma membrane
contact [33–35]. These abilities were inhibited in the
Ste20Ste5PM chimera in a manner that required both docking
and Cdk sites (Figures 4E and 4F). Hence, the chimera con-
verts Ste20 from a multifunctional kinase into a form that is
restricted to functioning in noncycling cells. Altogether, the
results clearly reveal the feasibility of creating newCdk regula-
tory circuits via a combination of Cln2 docking and Cdk phos-
phorylation sites, and they establish the Ste20Ste5PM chimera
as a functionally flexible platform with which to assay docking
site activity.
Functional Cln2 Docking Sites in Other Cdk Substrates
To assess whether the Cln2 docking behavior seen with Ste5
and Ste20 might be more widespread, we searched for similar
sites in other Cdk substrates.Matches to the LxxPFxFmotif or
the core Ste5 site (LLPP) were too numerous for a proteome-
wide analysis. Nevertheless, we scanned the sequences of
known Cln1/2-Cdc28 targets and Cln2 binding partners, plus
Cdc28 substrates found in large-scale screens [4, 29, 36, 37],
for Leu/Pro-rich sequence motifs that are conserved among
fungal orthologs and lie outside of known or predicted struc-
tural domains. Although not comprehensive, as an initial test
case we chose seven such sequences (from Sic1, Whi5, Srl3,
Bem3, Tus1, Exo84, and Pea2; see Figure S4), including one
recently implicated in Cln2-Cdc28 phosphorylation of Sic1
[38]. We then tested these sequences for their ability to func-
tionally substitute for the Ste5/Ste20 docking sites, usingtwo experimental settings: (1) Cln2 inhibition of signaling by
the Ste20Ste5PM chimera, and (2) Cln2-driven phosphorylation
of the Ste5 N terminus.
Remarkably, the majority of these sequences had measur-
able activity. In the signaling assays (Figure 5A), theymediated
Cln2 inhibition to varying degrees, from strong (Sic1, Whi5,
Exo84) to moderate (Tus1, Pea2) to weak (Bem3); only the
Srl3 sequence was ineffective. Importantly, their inhibitory
effects were a specific response to Cln2 expression, and no
nonspecific effects were seen. The three most potent se-
quences contain exact matches to the Ste5 LLPP motif (Fig-
ure S4B), though it is notable that each was in fact more potent
than the Ste5 sequence in these assays (Figure 5A); thus, addi-
tional context features likely influence the efficacy of thismotif.
Similarly, the Pea2 sequence closely resembles the motif in
Ste20 and yet was less potent. The phosphorylation assays
yielded similar overall results, with a range of activity (Fig-
ure 5B; Figure S4C). The relative activities in the two assays
were generally correlated, but there were some discrepancies;
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1621for example, the Whi5 and Pea2 sequences were each weaker
in the phosphorylation assay than the sequences with which
they showed comparable potency in the signaling assay.
Together, these results clearly establish the utility of each
assay for their ability to rapidly evaluate multiple candidate
Cln2 docking sites and to compare efficacy in parallel. Overall,
given the large fraction of sequences that were effective, the
findings suggest that Cln2 recognition sites of various
strengths may be quite prevalent among Cln-Cdk targets.
The Phosphorylation Role of Docking Sites
Is Cyclin Specific
Finally, we tested whether the Cln2 docking sites enhance
phosphorylation by all forms of cyclin-Cdk or only by specific
forms. We used the Ste51–260 fragment as a starting substrate
and monitored its phosphorylation by inducing expression
of different cyclins in asynchronous cells (Figure 6A). In the
absence of any docking site, none of the cyclins drove ap-
preciable phosphorylation. When Cln2 docking sites from
Ste5, Ste20, or Exo84 were appended to this substrate,phosphorylation was enhanced in a manner that was clearly
cyclin specific. Cln2 was generally most effective, followed
by Cln1. (With the Ste20 site, Clb2 could drive some weak
phosphorylation detectable in longer exposures.) As a further
test, we fused the same substrate to a different type of docking
site: namely, a short sequence containing an RXL motif from
Fin1, a Cdk substrate that is normally preferred by Clb5 [13].
This motif switched the cyclin preference and caused phos-
phorylation to be driven strongly by Clb5, plus moderately by
Clb2 (Figure 6A, bottom). (It is noteworthy that the band
patterns were not identical, suggesting a different extent or
distribution of phosphorylation events.) These results clearly
indicate that Cdk sites in the Ste5 N terminus are intrinsically
capable of being phosphorylated by several different cyclin-
Cdk forms, but they are not effectively phosphorylated in vivo
in the absence of cyclin-specific docking sites, and hence this
provides specificity to the Cdk phosphorylation.
Discussion
In this study, we identified docking sites for the yeast G1/S
cyclins in several Cdk substrates. These sites bind preferen-
tially to Cln2 and enhance phosphorylation of Cdk substrates
in a cyclin-specific manner in vivo. They are also functionally
modular, in that they can promote phosphorylation at a variety
of distances and positions relative to the Cdk sites, and the
cyclin specificity of phosphorylation can be switched by
exchanging docking sites. We exploited this functional modu-
larity to rewire a Cdk regulatory circuit so as to change the
target of Cln2-Cdc28 regulation in the pheromone response
pathway and to identify candidate Cln2 docking sites in
several other Cdk substrates. The relative ease with which
these other sites were found suggests that there may be
numerous examples of such sites for the G1 or G1/S cyclins
in yeast. Indeed, recent studies from another group show
that the Sic1 sequence that we used to drive Cln2-Cdc28
phosphorylation of heterologous substrates does in fact
promote phosphorylation of Sic1 itself and can also act as
a competitive inhibitor of other Cln2-Cdc28 substrates [38].
Collectively, these findings suggest that docking interactions
play a prevalent but previously unappreciated role in driving
phosphorylation of G1/S Cdk substrates.
The use of separate docking and phosphorylation sites
offers functional and regulatory flexibility. At one extreme, it
can allow different kinases to phosphorylate the same sites,
as we observed by replacing a Cln2 docking site with an RXL
motif favored byB-type cyclins. It may also allow the sequence
requirements at phosphorylation sites to be relaxed. Although
most kinases favor certain residues flanking the phosphoryla-
tion site [3, 39], this ideal context may not be present or toler-
ated in all relevant substrates. Indeed, proteome-wide analysis
[37] suggests that roughly two thirds of Cdk sites in yeast are
not ‘‘consensus’’ sites (S/T-P-X-K/R). In Ste5, none of the eight
N-terminal Cdk sites matches this consensus. The presence of
a Cln2 docking site converts the Ste5 N terminus from a weak
substrate into a better substrate, but only for Cln1/2-Cdc28.
This enhancement may compensate for poor sequence con-
text, which in turn could minimize use by other cyclin-Cdks,
thus providing a regulatory benefit. Other possible benefits
of cyclin docking interactions are as follows: (1) they may
enhance Cdk phosphorylation even for substrates that are
not cyclin specific, (2) they may help drive multisite phosphor-
ylation of Cdk substrates [40], and (3) they may impart useful
regulatory behavior by fostering interplay with competitors
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1622or other bound factors. Indeed, the Cln2 docking site in Ste5
overlaps a binding site for the phosphatase Ptc1 [28], and
hence these two factors may compete for access to Ste5
in vivo. Overlapping cyclin and phosphatase binding sites
have also been found in the mammalian protein Rb [41], sug-
gesting a common theme.
Differences in docking strength may impact the extent and/
or timing of substrate phosphorylation [40]. For example, the
docking sites in Ste5 and Ste20 bind stronger to Cln2 than
Cln1, and such differences could contribute to disparities in
efficacy seen for these two cyclins [16, 42, 43]. We also
observed varying degrees of potency for different Cln2 dock-
ing sites, though the responsible sequence features remain
uncertain. The Ste5 and Ste20 sites share an LxxPFxF motif
and an overall enrichment in Leu, Pro, and/or hydrophobic
residues, which was used as a criterion to identify additional
sites. An LLPP motif is shared by several of the strong sites,
but the docking site in Ste20 does not match this motif and
yet is very potent. Thus, deducing the key sequence features
of Cln2 docking sites will require subsequent study, as will
determination of whether they bind directly to the cyclin versus
the cyclin-Cdk complex.
Subcellular localization can also contribute to functional
specialization of cyclins [44–46]. Hence, in addition to driving
phosphorylation in cis, some cyclin docking sites may help
localize cyclins and/or promote phosphorylation in trans of
other proteins in the same complex or subcellular locale [47].
In fact, prior to our discovery that it binds Cln2, we originally
found that the Cln2 docking site in Ste20 could trigger hy-
perpolarized growth when overexpressed and membrane-
localized [33]; in retrospect, this phenotype could result from
the generation of excess cortical binding sites for Cln2, which
promotes apical polarized growth [48]. Several Cln1/2-Cdc28
substrates are involved in cell polarity [4] (see Figure S4
legend), so it will be of interest to determine whether they
each contain Cln1/2 docking sites or whether docking sites
in some can serve a scaffolding role that promotes Cdk phos-
phorylation of cobound or colocalized substrates. Synthetic
approaches, such as those described here, can be used to
discover these docking sites as well as to characterize their
functional properties and activities in a standardized setting,
which ultimately can illuminate how the regulatory behavior
of native proteins and pathways arises from the combined
properties of individual motifs.
Experimental Procedures
Detailed experimental procedures are described in the Supplemental
Information, which also lists all yeast strains and plasmids and describes
which were used for each experiment.
Phosphorylation Assays
Cells harboring epitope-tagged proteins and PGAL1 glutathione S-trans-
ferase (GST) cyclin constructs were induced with galactose for 1–3 hr.
Cell extracts were prepared by glass bead lysis in trichloroacetic acid
solution [49], and proteins were analyzed by SDS-PAGE and immunoblot-
ting. To follow phosphorylation in synchronous cultures, we arrested a
cdc15-2 strain harboring tagged proteins at 37C for 3 hr and then
released it at 25C. Aliquots were taken at 20 min intervals to prepare
protein samples and score bud emergence.
Signaling Assays
To measure effects of PGAL1-CLN2 on pheromone response, we grew cells
in raffinosemedia, induced themwith galactose, and then treated themwith
a factor. MAPK phosphorylation was measured by anti-phospho-p44/42
immunoblots [50]. FUS1-lacZ expression wasmeasured by b-galactosidase
assay [12, 51].GST Binding Assays
Cultures harboring PGAL1-GST fusion proteins and cyclin-myc13 constructs
were induced with 2% galactose for 3 hr. Extracts were prepared by glass
bead lysis in a nonionic detergent buffer [51]. Aliquots were reserved and
then GST fusions and cobound proteins were collected with glutathione Se-
pharose beads and analyzed by SDS-PAGE and immunoblotting.
Supplemental Information
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.cub.2011.08.033.
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